Medtronic reports FDA Panel's affirmative votes on AMPLIFY rhBMP-2 Matrix for posterolateral spine fusion
Links shared publicly online about this topic.
- 990total visits
Medtronic reports FDA Panel's affirmative votes on AMPLIFY rhBMP-2 Matrix for posterolateral spine fusion
The U.S. Food and Drug Administration (FDA) Orthopaedic and Rehabilitation Devices Panel today voted 9 for and 4 against (1 abstention) on safety and 10 for and 3 against (1 abstention) on effectiveness, that data including results from a large, prospective randomized clinical trial demonstrated the safety and effectiveness of AMPLIFY" rhBMP-2 Matrix for fusions of the lower spine in patients with degenerative disc disease.
View full resource at news-medical.net
Tags: Disease and Condition, Drug, Clinical Trial, FDA
Most Recently Shared on July 28, 2010 at 9:27 am By:
Medtronic reports FDA Panel's affirmative votes on AMPLIFY rhBMP-2 Matrix for posterolateral spine fusion: The U.S... http://bit.ly/ciM344
Advertisement
